Trials / Conditions / Early Stage Parkinson's Disease

Early Stage Parkinson's Disease

8 registered clinical trials studyying Early Stage Parkinson's Disease.

Status	Trial	Sponsor	Phase
Completed	A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study NCT04658186	UCB Biopharma SRL	Phase 2
Terminated	Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Diseas NCT01048229	Qualissima	Phase 4
Completed	The Effects of Aplindore on the Treatment of Signs and Symptoms of Parkinson's Disease NCT00623324	Ligand Pharmaceuticals	Phase 2
Completed	An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients NCT00335374	Solvay Pharmaceuticals	Phase 3
Completed	An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients NCT00332917	Solvay Pharmaceuticals	Phase 3
Completed	SLV308 for Treatment of Patients With Early Parkinson's Disease NCT00269516	Solvay Pharmaceuticals	Phase 3
Completed	An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkins NCT00599196	UCB Pharma	Phase 3
Completed	An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkins NCT00594165	UCB Pharma	Phase 3